Basic HTML Version
Annual Report 2013
KPJ HEALTHCARE BERHAD
146
The Group’s Ancillary Services
segment incorporates a wide
spectrum of integrated services that
complement KPJ’s overall healthcare
services, offering and support the
operations of our network of hospitals.
This multi-dimensional interplay of
services is doing much to help us keep
our operating costs low while at the
same time helping generate alternate
streams of income for the Group.
Ancillary
Services
Augmenting
Our Overall
Service Offering
The year saw revenue on the Ancillary Services
front improving by 9% to RM752.7 million in 2013
from RM689.6 million in 2012. The segment’s
higher revenue was due to an upsurge in
activities connected to the marketing and
distribution of pharmaceutical, medical and
surgical products, as well as higher demand
for pathology and laboratory services. All these
activities grew in tandem with the increased
revenue from the Group’s hospitals.
Fast Growing Laboratory Services Network
Lablink (M) Sdn Bhd is wholly owned by
Kumpulan Perubatan (Johor) Sdn Bhd, a
subsidiary of the Group. With over two decades
of experience to its name, Lablink (M) Sdn Bhd
is responsible for managing 20 KPJ hospital
laboratories and the laboratory at Nilai Medical
Centre. With a vision to be “The Preferred
Healthcare Provider” in Malaysia, Lablink
is focused on delivering superior laboratory
services with greater ef ciency and speed.
With all the Group’s laboratories today under
one central authority, we are reaping the
bene ts of having better bulk purchasing power
as well as standardised systems and processes
to ensure consistency and quality control. On
top of this, we are deriving cost bene ts from
centralising certain tests, as well as ensuring
speedier results by linking all our laboratories
through the Laboratory Information System
(LIS) network.
Today, Lablink continues to add to its
comprehensive range of tests with its offer
of haematology, biochemistry, immunoassay,
microbiology, molecular testing, histopathology,
cytopathology, allergy and auto-immune
antibody tests as well as therapeutics
drugs monitoring. Lablink is also tasked
with developing, installing, maintaining and
marketing the LIS software.
In 2013, Lablink recorded a total of 8.0 million
test requests, a 9% increment over 2012’s result.
The bulk of Lablink’s revenue came from higher
requests mostly for microbiology and general
tests which increased by 28.4% and 29.1%
respectively.
Business
Review
Ancillary Services